Search Results - "Memmos, D"

Refine Results
  1. 1

    P174 Urinary excretion of Th1, Th2 and Th17 cytokines in idiopathic focal segmental glomerulosclerosis: Preliminary results from a single center by Stangou, M., Spartalis, M., Papagianni, A., Liakou, H., Kasimatis, S., Efstratiadis, G., Memmos, D.

    Published in Cytokine (Philadelphia, Pa.) (01-09-2012)
    “…Idiopathic Focal Segmental Glomerusclerosis (FSGS) usually leads to end stage renal disease. Cytokines excreted in the urine may represent immunological…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis by Papagianni, Aikaterini, Kokolina, Elisavet, Kalovoulos, Michalis, Vainas, Andreas, Dimitriadis, Chrisostomos, Memmos, Dimitrios

    Published in Nephrology, dialysis, transplantation (01-05-2004)
    “…Background. Recent evidence suggests that endothelial cell adhesion molecules may participate in the initiation and progression of atherosclerotic vascular…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Contrast media-induced nephropathy: case report and review of the literature focusing on pathogenesis by Efstratiadis, G, Pateinakis, P, Tambakoudis, G, Pantzaki, A, Economidou, D, Memmos, D

    Published in Hippokratia (01-04-2008)
    “…Contrast media administration during diagnostic and invasive procedures in high risk patients for nephrotoxicity is a common problem in clinical practice. The…”
    Get full text
    Journal Article
  6. 6

    Immunosuppressive Therapy and Clinical Evolution in Forty-nine Patients with Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis by KOKOLINA, E., ALEXOPOULOS, E., DIMITRIADIS, C., VAINAS, A., GIAMALIS, P., PAPAGIANNI, A., EKONOMIDOU, D., MEMMOS, D.

    Published in Annals of the New York Academy of Sciences (01-06-2005)
    “…: Immunosuppressive therapy and clinical evolution were studied in 49 patients (29 females) with antineutrophil cytoplasmic antibody (ANCA)‐associated…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Cyclosporine and its metabolites before and 2 h post-dose: comparative measurements of a monoclonal and a polyclonal immunoassay by Vyzantiadis, T, Belechri, AM, Memmos, D, Axiotou, M, Vyzantiadis, A, Papadimitriou, M

    Published in Clinical transplantation (01-06-2003)
    “…:  The aim of the study was to investigate the better accuracy of the 2‐h post‐dose (C2) levels of cyclosporine (CyA), compared with the pre‐dose (C0) levels…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    A case of Campylobacter jejuni peritonitis in a patient on continuous ambulatory peritoneal dialysis by Bibashi, E, Kokolina, E, Owen, R, Thwaites, R, Sofianou, D, Memmos, D

    Published in Clinical microbiology newsletter (01-08-2004)
    “…In spite of improvements in continuous peritoneal dialysis (CAPD) techniques, such as disconnect systems, peritonitis remains an important reason for method…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis by Kirmizis, Dimitrios, Papagianni, Aikaterini, Belechri, Anna-Maria, Memmos, Dimitrios

    Published in Nephrology, dialysis, transplantation (01-07-2011)
    “…Background . In the present prospective, controlled, observational cohort study, we investigated the effects of the use of a vitamin E-coated membrane dialyser…”
    Get full text
    Journal Article
  17. 17

    Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome by Alexopoulos, Efstathios, Papagianni, Aikaterini, Tsamelashvili, Mzia, Leontsini, Maria, Memmos, Dimitrios

    Published in Nephrology, dialysis, transplantation (01-11-2006)
    “…Background. Cyclosporine A (CyA) has been shown to be effective in membranous nephropathy (MN). However, the optimal dose and the duration of treatment remain…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20